All the information you need about LABORATOIRES DERGAM to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-27 | Partially confidential | 2021-12-31 | Complete |
| 2021-06-23 | Partially confidential | 2020-12-31 | Complete |
| 2020-09-25 | Partially confidential | 2019-12-31 | Complete |
| 2019-05-27 | Partially confidential | 2018-12-31 | Complete |
| 2018-07-03 | Public | 2017-12-31 | Complete |
| 2017-07-12 | Public | 2016-12-31 | Complete |
| Name | LABORATOIRES DERGAM |
| Siren | 325070399 |
| Closing | 2019-12-31 |
| Registry code | 7501 |
| Registration number | 75827 |
| Management number | 1982B08367 |
| Activity code | 4645Z |
| Closing date n-1 | 2018-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2020-09-25 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 75014 PARIS |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AF Concessions, Patents and Similar Rights | 57 161.00 | 26 234.00 | 30 927.00 | 57 161.00 |
AJ Other Intangible Assets | 84.00 | 84.00 | 84.00 | |
AR Technical installations, industrial equipment and tools | 8 635.00 | 8 635.00 | 8 635.00 | |
AT Other tangible assets | 154 563.00 | 23 644.00 | 130 920.00 | 154 563.00 |
BH Other financial assets | 12 681.00 | 12 681.00 | 12 681.00 | |
BJ TOTAL (I) | 261 272.00 | 78 597.00 | 182 675.00 | 261 272.00 |
BT Goods | 339 822.00 | 339 822.00 | 339 822.00 | |
BX Customers and related accounts | 372 751.00 | 372 751.00 | 372 751.00 | |
BZ Other receivables | 15 377.00 | 15 377.00 | 15 377.00 | |
CF Cash and cash equivalents | 681 198.00 | 681 198.00 | 681 198.00 | |
CH Prepaid expenses | 3 857.00 | 3 857.00 | 3 857.00 | |
CJ TOTAL (II) | 1 413 006.00 | 1 413 006.00 | 1 413 006.00 | |
CO Grand total (0 to V) | 1 674 278.00 | 78 597.00 | 1 595 681.00 | 1 674 278.00 |
CU Other investments | 8 147.00 | 8 147.00 | 8 147.00 | |
CX Development or Research and Development Expenses | 20 000.00 | 20 000.00 | 20 000.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 80 000.00 | 80 000.00 | ||
DD Legal reserve (1) | 8 000.00 | 8 000.00 | ||
DF Regulated reserves (1) | 20 400.00 | 20 400.00 | ||
DG Other reserves | 560 000.00 | 560 000.00 | ||
DH Retained earnings | 14 501.00 | 14 501.00 | ||
DI RESULTS FOR THE YEAR (Profit or Loss) | 516 029.00 | 516 029.00 | ||
DL TOTAL (I) | 1 198 930.00 | 1 198 930.00 | ||
DU Loans and Debts from Credit Institutions (3) | 136 956.00 | 136 956.00 | ||
DV Miscellaneous Loans and Financial Debts (4) | 81 041.00 | 81 041.00 | ||
DX Trade payables and related accounts | 154 688.00 | 154 688.00 | ||
DY Tax and social security liabilities | 19 051.00 | 19 051.00 | ||
EA Other liabilities | 5 012.00 | 5 012.00 | ||
EC TOTAL (IV) | 396 750.00 | 396 750.00 | ||
EE Grand total (I to V) | 1 595 681.00 | 1 595 681.00 | ||
EG Accrued income and payables due within one year | 293 436.00 | 293 436.00 | ||
